首页> 美国政府科技报告 >Early Detection of NF1 Brain Tumor Growth and Treatment Response by MRI, MRS and PET in a Trial of Novel Antitumor Drugs
【24h】

Early Detection of NF1 Brain Tumor Growth and Treatment Response by MRI, MRS and PET in a Trial of Novel Antitumor Drugs

机译:新型抗肿瘤药物试验中mRI,mRs和pET早期检测NF1脑肿瘤生长和治疗反应

获取原文

摘要

This, the final report for all clinical research studies conducted under the US Army BAA for Neurofibromatosis type 1, reviews the progress made between January, 1994 (Army approved start date) and October, 1997 (completion of data accrual for all studies) concerning the conduct and preliminary results from NF-1 Clinical Trials Consortium studies. It is organized into three sections: (1) a description of the clinical trials structure and organization; (2) a review of the randomized phase II clinical trial results for the treatment of NF-I patient with optic pathway I hypothalamic gliomas or plexiform neurofibromas; (3) a review of the methods development and results for multimodality neuroimaging studies in NF-i patients with newly-diagnosed or progressive optic pathway / hypothalamic gliomas or brain stem gliomas.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号